BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11454507)

  • 21. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
    Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Na(+)/I(-) symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues.
    Lacroix L; Mian C; Caillou B; Talbot M; Filetti S; Schlumberger M; Bidart JM
    Eur J Endocrinol; 2001 Mar; 144(3):297-302. PubMed ID: 11248751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene.
    Presta I; Arturi F; Ferretti E; Mattei T; Scarpelli D; Tosi E; Scipioni A; Celano M; Gulino A; Filetti S; Russo D
    BMC Cancer; 2005 Jul; 5():80. PubMed ID: 16029487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semi-quantitative comparison of the differentiation markers and sodium iodide symporter messenger ribonucleic acids in papillary thyroid carcinomas using RT-PCR.
    Tanaka K; Otsuki T; Sonoo H; Yamamoto Y; Udagawa K; Kunisue H; Arime I; Yamamoto S; Kurebayashi J; Shimozuma K
    Eur J Endocrinol; 2000 Apr; 142(4):340-6. PubMed ID: 10754474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.
    Venkataraman GM; Yatin M; Marcinek R; Ain KB
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2449-57. PubMed ID: 10404820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Na+/I- symporter and Pendred syndrome genes in trophoblast cells.
    Bidart JM; Lacroix L; Evain-Brion D; Caillou B; Lazar V; Frydman R; Bellet D; Filetti S; Schlumberger M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4367-72. PubMed ID: 11095481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency.
    Espadinha C; Santos JR; Sobrinho LG; Bugalho MJ
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):629-35. PubMed ID: 18710471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium/iodide symporter (NIS) and pendrin are expressed differently in hot and cold nodules of thyroid toxic multinodular goiter.
    Russo D; Bulotta S; Bruno R; Arturi F; Giannasio P; Derwahl M; Bidart JM; Schlumberger M; Filetti S
    Eur J Endocrinol; 2001 Nov; 145(5):591-7. PubMed ID: 11720877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma.
    Wang ZF; Liu QJ; Liao SQ; Yang R; Ge T; He X; Tian CP; Liu W
    Tumori; 2011; 97(4):540-6. PubMed ID: 21989446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation?
    Chiefari E; Brunetti A; Arturi F; Bidart JM; Russo D; Schlumberger M; Filetti S
    BMC Cancer; 2002 Dec; 2():35. PubMed ID: 12475396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of sodium iodide symporter expression in differentiated thyroid carcinomas.
    Morari EC; Marcello MA; Guilhen AC; Cunha LL; Latuff P; Soares FA; Vassallo J; Ward LS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):247-54. PubMed ID: 21521301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of thyrotropin receptor gene suggests a high-risk subgroup for oncocytic adenoma.
    Mirebeau-Prunier D; Guyétant S; Rodien P; Franc B; Baris O; Rohmer V; Reynier P; Tourmen Y; Malthièry Y; Savagner F
    Eur J Endocrinol; 2004 Mar; 150(3):269-76. PubMed ID: 15012610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.
    Joba W; Spitzweg C; Schriever K; Heufelder AE
    Thyroid; 1999 May; 9(5):455-66. PubMed ID: 10365677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells.
    Passon N; Puppin C; Lavarone E; Bregant E; Franzoni A; Hershman JM; Fenton MS; D'Agostino M; Durante C; Russo D; Filetti S; Damante G
    Thyroid; 2012 May; 22(5):487-93. PubMed ID: 22510021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
    Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
    Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake.
    Mian C; Barollo S; Pennelli G; Pavan N; Rugge M; Pelizzo MR; Mazzarotto R; Casara D; Nacamulli D; Mantero F; Opocher G; Busnardo B; Girelli ME
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):108-16. PubMed ID: 17854396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
    Carvalho DP; Ferreira AC
    Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iodide symporter gene expression in normal and transformed rat thyroid cells.
    Trapasso F; Iuliano R; Chiefari E; Arturi F; Stella A; Filetti S; Fusco A; Russo D
    Eur J Endocrinol; 1999 May; 140(5):447-51. PubMed ID: 10229912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer.
    Pallante P; Federico A; Berlingieri MT; Bianco M; Ferraro A; Forzati F; Iaccarino A; Russo M; Pierantoni GM; Leone V; Sacchetti S; Troncone G; Santoro M; Fusco A
    Cancer Res; 2008 Aug; 68(16):6770-8. PubMed ID: 18701502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.